Treatment with perilesional injections of pentoxifylline in patients with Peyronie's disease improves the therapeutic effect of oral and topical antioxidant therapy
Abstract
To the Editor,
We conducted a retrospective study to demonstrate that it is possible to achieve better therapeutic outcomes through combining perilesional injections of pentoxifylline (PTX) with oral antioxidants and the local application of a cream containing antioxidants and a gel containing diclofenac in patients with Peyronie's disease (PD)...
References
- Pryor JP, Ralph DJ. Clinical presentations of Peyronie’s disease. Int. J Impot Res. 2002; 14:414–417. DOI: https://doi.org/10.1038/sj.ijir.3900877
- Garaffa G, Trost LW, Serefoglu EC, et al. Understanding the course of Peyronie's disease. Int J Clin Pract. 2013; 67:781–788. DOI: https://doi.org/10.1111/ijcp.12129
- Brant WO, Dean RC, Lue TF. Treatment of Peyronie's disease with oral pentoxifylline. Nat Clin Pract Urol. 2006; 3:111-115. DOI: https://doi.org/10.1038/ncpuro0409
- Smith JF, Shindel AW, Huang YC, et al. Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease. Asian J Androl. 2011; 13:322–325. DOI: https://doi.org/10.1038/aja.2010.117
- Ibrahim A, Gazzard L, Alharbi M, et al. Evaluation of Oral Pentoxifylline, Colchicine, and Penile Traction for the Management of Peyronie's Disease. Sex Med. 2019; 7:459–463. DOI: https://doi.org/10.1016/j.esxm.2019.07.003
- Paulis G, Barletta D, Turchi P, et al. Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie’s disease: A case-control study. Res Rep Urol. 2016; 8:1-10. DOI: https://doi.org/10.2147/RRU.S97194
Metrics
Citations and online attention from Dimensions, Altmetric and PlumX.
License
Copyright (c) 2025 the Author(s)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.